Analysis of Flow Cytometric Enumeration of CD34+ cells in Leukapheresis Product from South Indian Cancer Centre

Background: The success of peripheral blood stem cell (PBSC) transplant often relies on CD34+ cells counting. As the assay needs to be repeated in duplicate, this study was conducted to observe the variations between the duplicates with respect to concentration of leukapheresis product. Methods: The...

Full description

Bibliographic Details
Main Authors: Mohandoss Murugesan, Chandran K Nair, Sangeetha K Nayanar, Kalyana Chakravarthy Pentapati
Format: Article
Language:English
Published: Light House Polyclinic Mangalore 2019-04-01
Series:Online Journal of Health & Allied Sciences
Subjects:
Online Access:https://www.ojhas.org/issue69/2019-1-7.html
_version_ 1818642054095306752
author Mohandoss Murugesan
Chandran K Nair
Sangeetha K Nayanar
Kalyana Chakravarthy Pentapati
author_facet Mohandoss Murugesan
Chandran K Nair
Sangeetha K Nayanar
Kalyana Chakravarthy Pentapati
author_sort Mohandoss Murugesan
collection DOAJ
description Background: The success of peripheral blood stem cell (PBSC) transplant often relies on CD34+ cells counting. As the assay needs to be repeated in duplicate, this study was conducted to observe the variations between the duplicates with respect to concentration of leukapheresis product. Methods: The assay followed was single platform method - ISHAGE protocol published by the International Society of Haematotherapy and Graft Engineering. New parameter named variation index was used to compare the difference between the duplicates. Results: We present our data on 111 samples collected from leukapheresis product. 10% of the assay did not meet the criteria and required repeat testing. We observed no significant difference between the duplicate samples with respect to low (CD34+ cells/µl<500; P=0.632), Medium: 500 to 1000 CD34+ cells/µl, P=0.085 and High >1000 CD34+ cells/µl, P=0.864). Conclusion: Testing the CD34 enumeration in duplicate and verifying its repeatability for variation index of less than 10 will help in accurately determining CD34+ dose calculations.
first_indexed 2024-12-16T23:36:57Z
format Article
id doaj.art-848efb73107145b68905e883901b4fb7
institution Directory Open Access Journal
issn 0972-5997
0972-5997
language English
last_indexed 2024-12-16T23:36:57Z
publishDate 2019-04-01
publisher Light House Polyclinic Mangalore
record_format Article
series Online Journal of Health & Allied Sciences
spelling doaj.art-848efb73107145b68905e883901b4fb72022-12-21T22:11:44ZengLight House Polyclinic MangaloreOnline Journal of Health & Allied Sciences0972-59970972-59972019-04-01181Analysis of Flow Cytometric Enumeration of CD34+ cells in Leukapheresis Product from South Indian Cancer CentreMohandoss Murugesan0Chandran K Nair1Sangeetha K Nayanar2Kalyana Chakravarthy Pentapati3Department of Transfusion Medicine, Malabar Cancer Centre, Thalassery, KeralaDepartment of Clinical Hematology, Malabar Cancer Centre, Thalassery, KeralaDepartment of Oncopathology, Malabar Cancer Centre, Thalassery, KeralaDepartment of Public Health Dentistry, Manipal College of Dental Sciences, Manipal Academy of Higher Education, Manipal, KarnatakaBackground: The success of peripheral blood stem cell (PBSC) transplant often relies on CD34+ cells counting. As the assay needs to be repeated in duplicate, this study was conducted to observe the variations between the duplicates with respect to concentration of leukapheresis product. Methods: The assay followed was single platform method - ISHAGE protocol published by the International Society of Haematotherapy and Graft Engineering. New parameter named variation index was used to compare the difference between the duplicates. Results: We present our data on 111 samples collected from leukapheresis product. 10% of the assay did not meet the criteria and required repeat testing. We observed no significant difference between the duplicate samples with respect to low (CD34+ cells/µl<500; P=0.632), Medium: 500 to 1000 CD34+ cells/µl, P=0.085 and High >1000 CD34+ cells/µl, P=0.864). Conclusion: Testing the CD34 enumeration in duplicate and verifying its repeatability for variation index of less than 10 will help in accurately determining CD34+ dose calculations.https://www.ojhas.org/issue69/2019-1-7.htmlCD34+ cells EnumerationFlowcytometryISHAGE
spellingShingle Mohandoss Murugesan
Chandran K Nair
Sangeetha K Nayanar
Kalyana Chakravarthy Pentapati
Analysis of Flow Cytometric Enumeration of CD34+ cells in Leukapheresis Product from South Indian Cancer Centre
Online Journal of Health & Allied Sciences
CD34+ cells Enumeration
Flowcytometry
ISHAGE
title Analysis of Flow Cytometric Enumeration of CD34+ cells in Leukapheresis Product from South Indian Cancer Centre
title_full Analysis of Flow Cytometric Enumeration of CD34+ cells in Leukapheresis Product from South Indian Cancer Centre
title_fullStr Analysis of Flow Cytometric Enumeration of CD34+ cells in Leukapheresis Product from South Indian Cancer Centre
title_full_unstemmed Analysis of Flow Cytometric Enumeration of CD34+ cells in Leukapheresis Product from South Indian Cancer Centre
title_short Analysis of Flow Cytometric Enumeration of CD34+ cells in Leukapheresis Product from South Indian Cancer Centre
title_sort analysis of flow cytometric enumeration of cd34 cells in leukapheresis product from south indian cancer centre
topic CD34+ cells Enumeration
Flowcytometry
ISHAGE
url https://www.ojhas.org/issue69/2019-1-7.html
work_keys_str_mv AT mohandossmurugesan analysisofflowcytometricenumerationofcd34cellsinleukapheresisproductfromsouthindiancancercentre
AT chandranknair analysisofflowcytometricenumerationofcd34cellsinleukapheresisproductfromsouthindiancancercentre
AT sangeethaknayanar analysisofflowcytometricenumerationofcd34cellsinleukapheresisproductfromsouthindiancancercentre
AT kalyanachakravarthypentapati analysisofflowcytometricenumerationofcd34cellsinleukapheresisproductfromsouthindiancancercentre